Short- to mid-term results using autologous bone-marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease

Vascular and Endovascular Surgery

Volumn 45, Issue 5, 2011, Pages 398-406

  Franz, Randall W ^a   Shah, Kaushal J ^a   Johnson, Jason D ^b   Pin, Richard H ^a   Parks, Alan M ^c   Hankins, Thomas ^a   Hartman, Jodi F ^d   Wright, Michelle L ^d  

^a GRANT MEDICAL CENTER   (United States)

^b Doctors Hospital   (United States)

^c ALEGENT HEALTH   (United States)

^d Orthopaedic Research and Reporting Ltd   (United States)

Author keywords

bone marrow transplantation; chronic limb ischemia; ischemia; neoangiogenesis; peripheral arterial disease; stem cell therapy

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GANGRENE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEG AMPUTATION; LEG PAIN; LEG ULCER; LIMB SALVAGE; MALE; MONONUCLEAR CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; REST; TREATMENT OUTCOME; ULCER HEALING;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANKLE BRACHIAL INDEX; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAMUSCULAR; INTERMITTENT CLAUDICATION; LEG ULCER; LIMB SALVAGE; MALE; MIDDLE AGED; OHIO; PAIN MEASUREMENT; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; REOPERATION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 79960025458     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574411405545     Document Type: Article

References (37)

1. Attanasio S., Snell J. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review. Cardiol Rev. 2009 ; 17 (3). 115-120.
2. Norgren L., Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vas Surg. 45 (suppl): S5 - S67 ; 2007.
3. Fadini GP, Agostini C., Sartore S., Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis. 2007 ; 194 (1). 46-54. (Pubitemid 47464318)
4. Kajiguchi M., Kondo T., Izawa H., et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J. 2007 ; 71 (2). 196-201. (Pubitemid 46182692)
5. Napoli C., Farzati B., Sica V., et al. Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia. Eur J Cardio Prev Rehab. 2008 ; 15 (6). 709-718.
6. Amann B., Luedemann C., Ratei R., Schmidt-Lucke JA Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant. 2009 ; 18 (3). 371-380.
7. Bartsch T., Brehm M., Zeus T., Kogler G., Wernet P., Strauer BE. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study). Clin Res Cardiol. 2007 ; 96 (12). 891-899. (Pubitemid 350164931)
8. Esato K., Hamano K., Li TS, et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant. 2002 ; 11 (8). 747-752. (Pubitemid 36176786)
9. Hamano K., Li TS, Kobayashi T., et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery. 2001 ; 130 (1). 44-54. (Pubitemid 32626197)
10. Hattori R., Matsubara H. Therapeutic angiogenesis for severe ischemic heart diseases by autologous bone marrow cells transplantation. Mol Cell Biochem. 2004 ; 264 (1-2). 151-155. (Pubitemid 39366113)
11. Higashi Y., Kimura M., Hara K., et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation. 2004 ; 109 (10). 1215-1218. (Pubitemid 38372778)
12. Ikenaga S., Hamano K., Nishida M., et al. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res. 2001 ; 96 (2). 277-283. (Pubitemid 34969444)
13. Ishida A., Ohya Y., Sakuda H., et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J. 2005 ; 69 (10). 1260-1265. (Pubitemid 41382950)
14. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999 ; 103 (9). 1231-1236. (Pubitemid 29218292)
15. Kobayashi T., Hamano K., Li TS, et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res. 2000 ; 89 (2). 189-195. (Pubitemid 30196524)
16. Matoba S., Tatsumi T., Murohara T., et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008 ; 156 (5). 1010-1018.
17. Tachi Y., Fukui D., Wada Y., et al. Changes in angiogenesis-related factors in serum following autologous bone marrow cell implantation for severe limb ischemia. Expert Opin Biol Ther. 2008 ; 8 (6). 705-712. (Pubitemid 351860199)
18. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002 ; 360 (9331). 427-435.
19. Wester T., Jorgensen JJ, Stranden E., et al. Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study. Scand J Surg. 2008 ; 97 (1). 56-62. (Pubitemid 351449965)
20. Fadini GP, Agostini C., Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis. 2010 ; 209 (1). 10-17.
21. Iwase T., Nagaya N., Fujii T., et al. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation. 2005 ; 111 (3). 356-362. (Pubitemid 40165344)
22. Franz RW, Parks A., Shah KJ, Hankins T., Hartman JF, Wright ML Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease. J Vasc Surg. 2009 ; 50 (6). 1378-1390.
23. Rutherford RB, Baker JD, Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 ; 26 (3). 517-538. (Pubitemid 27408567)
24. Rutherford RB, Flanigan DP, Gupta SK, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986 ; 4 (3). 80-94. (Pubitemid 16056552)
25. Helisch A., Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation. 2003 ; 10 (1). 83-97. (Pubitemid 39004238)
26. Unthank JL, Sheridan KM, Dalsing MC Collateral growth in the peripheral circulation: a review. Vasc Endovasc Surg. 2004 ; 38 (4). 291-313. (Pubitemid 39079934)
27. Wahlberg E. Angiogenesis and arteriogenesis in limb ischemia. J Vasc Surg. 2003 ; 38 (1). 198-203. (Pubitemid 41123313)
28. De Vivo S., Palmer-Kazen U., Kalin B., Wahlberg E. Risk factors for poor collateral development in claudication. Vasc Endovasc Surg. 2005 ; 39 (6). 519-524. (Pubitemid 41790144)
29. Hedera P., Bujdakova J., Traubner P., Pancak J. Stroke risk factors and development of collateral flow in carotid occlusive disease. Acta Neurol Scand. 1998 ; 98 (3). 182-186. (Pubitemid 28435312)
30. Kilian JG, Keech A., Adams MR, Celermajer DS Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis. 2002 ; 13 (3). 155-159. (Pubitemid 34747963)
31. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001 ; 49 (3). 554-560. (Pubitemid 32146418)
32. Ceradini DJ, Gurtner GC Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med. 2005 ; 15 (2). 57-63. (Pubitemid 40693388)
33. Cetrulo CL Jr, Knox KR, Brown DJ, et al. Stem cells and distraction osteogenesis: endothelial progenitor cells home to the ischemic generate in activation and consolidation. Plast Recons Surg. 2005 ; 116 (4). 1053-1064. (Pubitemid 41324925)
34. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001 ; 104 (9). 1046-1052. (Pubitemid 32803883)
35. Parmar K., Mauch P., Vergilio JA, Sackstein R., Down JD Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA. 2007 ; 104 (13). 5431-5436. (Pubitemid 47175697)
36. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999 ; 5 (4). 434-438. (Pubitemid 29180584)
37. Heil M., Ziegelhoeffer T., Mees B., Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004 ; 94 (5). 573-574. (Pubitemid 38387738)